Atara Biotherapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $3,453 | $17,575 | $98,149 | $32,753 |
Gross Profit | 3,338 | 17,021 | 77,710 | 25,958 |
EBITDA | -3,330 | 3,598 | 40,822 | -10,595 |
EBIT | -3,366 | 3,362 | 39,027 | -11,695 |
Net Income | -4,303 | 2,387 | 38,010 | -12,693 |
Net Change In Cash | 3,453 | 17,575 | 98,149 | 32,753 |
Free Cash Flow | -9,787 | -7,318 | -28,138 | -24,561 |
Cash | 5,742 | 16,903 | 13,841 | 25,030 |
Basic Shares | 13,564 | 12,310 | 10,851 | 10,690 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $128,940 | $8,573 | $63,573 | $20,340 |
Gross Profit | 107,931 | -313 | 63,573 | 20,340 |
EBITDA | -75,749 | -265,997 | -222,264 | -331,117 |
EBIT | -80,800 | -270,826 | -227,917 | -340,462 |
Net Income | -85,403 | -276,126 | -228,302 | -340,141 |
Net Change In Cash | 128,940 | 8,573 | 63,573 | 20,340 |
Cost of Revenue | -14,390 | -94,320 | ||
Free Cash Flow | -68,963 | -194,200 | -274,623 | -231,102 |
Cash | 25,030 | 25,841 | 92,942 | 106,084 |
Basic Shares | 7,488 | 4,236 | 4,079 | 3,746 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.32 |
2025-06-30 | $0.19 |
2025-03-31 | $3.50 |
2024-12-31 | -$1.19 |
